ISG15 and breast carcinoma: Although these results suggest that ISG15 might function as an oncoprotein in bladder cells under certain circumstances, the underlying malignancy-causing mechanism appeared to differ from the ISGylation-related mechanism observed in breast cancer, which may be related to differences between the structure and function of bladder epithelium versus those of the glandular tissue of the breast.